Asthmatic Organoid Models: Custom construction of asthma organoid models for airway inflammation studies.Establishment of human rhinovirus C (HRV-C) infection models in respiratory organoids.
IntestiOrg System: Designed for intestinal epithelial organoids, featuring superior differentiation and self-renewal capabilities. Faithfully replicates intestinal villi structures and multicellular epithelial lineages.
Applications: Inflammatory bowel disease (IBD), microbiome-gut interactions, nutrient absorption studies.
Customized disease models via CRISPR gene editing, patient-derived cells, or cytokine induction.
Coverage: Respiratory diseases, cancers, autoimmune disorders, genetic/rare diseases.
Applications: Basic mechanism research, target validation, functional screening.
Same as above, with focus on genetic/rare disease modeling.
· High-throughput screening system for organoid-based drug discovery.
· Features: Automated liquid handling, image recording, efficacy statistics.
· Compatibility: Fluorescence imaging and flow cytometry equipment; adaptable to diverse organoid types.
· Custom optimization of culture systems for:
· Specific tissue sources (e.g., lung, intestine).
· Specialized disease models.
· Non-standard animal species.
· IntestiOrg: Proprietary term (retained as-is).
· HRV-C: Human Rhinovirus C (standard virology abbreviation).
· HTS: High-Throughput Screening (industry standard).
· CRISPR: Retained as standard genetic editing technology.
· Ethically sourced, traceable human tissues (e.g., intestine, lung, skin, tumors).
· All samples undergo rigorous ethical review and informed consent.
· Applications: Academic research, industrial drug screening.